Page 181 - medicina-integrativa_compress

174 PARTE II, SECCIÓN 2 NEUROLOGÍA

• Dosis oral de vitamina B 12 , 1.000 a 2.000 • Medicina china tradicional
mg cada 24 h. B B 1 (acupuntura). C 2 2
• Vitamina B 12 , inyección i.m. 1.000 μg dos
veces al mes. ■ Ejercicio

• Acuático.
B B 1
■ Fitofármacos
• Yoga.
• Ginkgo biloba, 120 a 240 mg cada 24 h. B B 1
C 1 • Pilates.
• Hipérico, 300 mg cada 8 h para la B B 1
depresión.
B B 2 2
■ Técnicas para reducir el estrés
• Bufera, 1 a 2 g cada 12 h o cada 8 h.
• Meditación.
B B 2 2
B B 1
■ Hormonas
■ Fármacos
• Estriol, 4 mg cada 12 h.
B B 2 2 • Corticoesteroides. A A 3 3
Testosterona: varones: 10 a 30 mg cada 24 h;
• Interferón beta.
mujeres: 2 a 5 mg cada 24 h. B B 2 2 A A 3 3
• Acetato de glatirámero.
DHEA: varones: 10 a 30 mg cada 24 h; A A 2 2
mujeres: 5 a 15 mg cada 24 h.
B B 2 2 • Mitoxantrona.
A A 3 3
• Natalizumab.
■ Sistemas de curación tradicionales
A A 3 3
• Ayurveda.
C 2 2

BIBLIOGRAFÍA 12. Frohman EM, Filippi M, Stuve O: Characterizing the mechanisms
of progression in multiple sclerosis. Arch Neurol 62:1345-1346,
1. Beck CA, Metz LM, Svenson LW, Patten SB: Regional variation 2005.
of multiple sclerosis prevalence in Canada. Mult Scler 11:516-519, 13. Esparza ML, Sasaki S, Kesteloot H: Nutrition, latitude, and multiple
2005. sclerosis morality: An ecologic study. Am J Epidemiol 142:733-777,
2. Haegert DG: Clinical multiple sclerosis occurs at one end of a 1995.
spectrum of CNS pathology: A modified threshold liability model 14. Mayer M: Essential fatty acids and related molecular and cellular
leads to new ways of thinking about the cause of clinical multiple mechanisms in multiple sclerosis: New looks at old concepts. Folia
sclerosis. Med Hypotheses 65:232-237, 2005. Biolog (Praha) 45:133-141, 1999.
3. Weinstock-Guttman B, Jacobs LD: What is new in the treatment 15. Jacob S, Zarei M, Kenton A, Allroggen H: Gluten sensitivity and
of multiple sclerosis. Drugs 59:401-410, 2000. neuromyelitis optica: Two case reports. J Neurol Neurosurg
4. Willer CJ, Ebers GC: Susceptibility to multiple sclerosis: Interplay Psychiatry 76:1028-1030, 2005.
between genes and environment. Curr Opin Neurol 13:241-247, 16. Reichelt KL, Jensen D: IgA antibodies against gliadin and gluten in
2000. multiple sclerosis. Acta Neurol Scand 110:239-241, 2004.
5. Frohman EM, Filippi M, Stuve O, et al: Characterizing the 17. Bains JS, Shaw CA: Neurodegenerative disorders in humans: The
mechanisms of progression in multiple sclerosis. Arch Neurol role of glutathione in oxidative stress-mediated neuronal death.
62:1345-1356, 2005. Brain Res Rev 25:335-358, 1997.
6. Visscher BR, Detels R, Coulson AH, et al: Latitude, migration, and 18. Packer L, Witt EH, Tritschler HJ: Alpha-lipoic acid as a biological
the prevalence of multiple sclerosis. Am J Epidemiol 106:470-475. antioxidant. Free Radic Biol Med 19:227-250, 1995.
1977. 19. Busse E, Zimmer G, Schopohl B, Kornhuber B: Influence of
7. Swank RL, Lerstad O, Strom A: Multiple sclerosis in rural Norway: alpha-lipoic acid on intracellular glutathione in vitro and in vivo.
Its geographical and occupational incidence in relation to nutrition. Arzneimittelf 42:829-831, 1992.
N Engl J Med 246:721-728, 1952. 20. Grant WB, Holick MF: Benefits and requirements of vitamin D
8. Huggins HA, Levy TL: Cerebrospinal fluid changes in multiple sclerosis for optimal health: A review. Alt Med Rev 10:94-111, 2005.
after dental amalgam removal. Altern Med Rev 3:295-300, 1998. 21. Hayes CE, Cantorna MT, DeLuca HF: Vitamin D and multiple
9. McGrother CW, Dugmore C, Phillips MJ, et al: Multiple sclerosis, sclerosis. Proc Soc Exp Biol Med 216:121-127, 1997.
dental caries, and fillings: A case-control study. Br Dent J 187: 22. Cantorna M, Humpai-Winter J, DeLuca H: Dietary calcium is a
261-264, 1999. major factor in 1,25-dihydroxycholecalciferol suppression of
10. Verstraeten T, Davis R, DeStefano F: Immunity to tetanus is experimental autoimmune encephalomyelitis in mice. J Nutr
protective against the development of multiple sclerosis. Med 129:1966-1971, 1999.
Hypotheses 65:966-969, 2005. 23. Kira J, Tobimatsu S, Goto I: Vitamin B 12 metabolism and massive
11. Faure E: Multiple sclerosis and hepatitis B vaccination: Could dose methyl vitamin B 12 therapy in Japanese patients with multiple
minute contamination of the vaccine by partial hepatitis B sclerosis. Int Med 33:82-86, 1994.
virus polymerase play a role through molecular mimicry? 24. Reynolds EH: Multiple sclerosis and vitamin B 12 metabolism.
Med Hypotheses 65:509-520, 2005. J Neuroimmunol 40:225-230, 1992.